Inflammation & Isolation: The Mental Health Side of Psoriasis

Psoriasis doesn’t just affect the skin — it shapes daily life, confidence, and mental health. In this episode, we talk with Dr. Scott Drew about how modern treatments reduce inflammation, improve mood, and help patients return to work, relationships, and everyday moments they once avoided. When care truly works, you see it: posture lifts, eye contact returns, and people start saying yes to life again.

We explore why mental health belongs in every psoriasis visit, how to talk about intimacy and emotional strain without stigma, and what the science really says about treatment safety. This conversation is a reminder that clearer skin isn’t just cosmetic — it’s a path back to living fully and without shame.

Thank you to Eli Lilly for sponsoring this podcast!

Transcript

Sponsor And Promise Of Relief

SPEAKER_02 0:00

This podcast is sponsored by Eli Lilly. I can make you not itch, I can make it look better, I can make you feel better. And not just the skin feel better, I can make you feel better all over. Right. So the first patient you identified of not wanting to have intimacy with your partner because you're embarrassed by the genital psoriasis or your partner is scared of a genital psoriasis. It's important for patients to understand that anxiety, depression, and SIB is part of the disease process.

SPEAKER_00 0:40

Welcome to Dermot Trotter, Don't Swear About Skin Care, where host Dr. Shannon C. Trotter, a board-certified dermatologist, sits down with fellow dermatologists and skincare experts to separate fact from fiction and simplify skincare. Let's get started.

Meet Dr. Scott Drew

Psoriasis Beyond The Skin

SPEAKER_01 0:58

Welcome to the Dermot Trotter Don't Swear About Skin Care podcast. I've got a very special guest on the show here today, Dr. Scott Drew, who is my program director in residency training. He practices at Dermatology Associates of Mid-Ohio, and he's a board-certified dermatologist and on the medical board for the National Psoriasis Foundation. So, needless to say, psoriasis is his thing, and that's what we're going to tackle today with mental health. Welcome to the podcast, Scott. It's great to have you here.

SPEAKER_02 1:23

Well, thank you, Dr. Schrotter. It's great to see you again and always fun to talk about psoriasis. We could we could have a podcast for hours because psoriasis is such an important disease, and we actually have ways to make people get back to life and away from their psoriasis.

SPEAKER_01 1:39

Well, I have to credit you because you taught me everything I know about psoriasis and not to be afraid to treat the patient and not just their psoriasis, but the whole patient. You know, you really emphasized that when we were going through a clinic and really just understanding how psoriasis impacts patients beyond just their skin. You know, the emotional toll that it takes on people, it takes them out of life, it takes them out of their activities as well. So I wanted to know if you could talk about that, what you've seen with patients and really how psoriasis has impacted their life.

Stigma, Shame, And Daily Losses

Quality Of Life Becomes Central

Make Mental Health Part Of Care

SPEAKER_02 2:09

So I don't know if I have ever talked to someone about their psoriasis without getting some response by sentence two or three that implies some degree of diminishing their quality of life. Whether it is work-related, whether it's embarrassment, whether it's intimacy issues, once you drill down into why they're there, the word embarrassment or ashamed or what have I done wrong, or uh, or what I've missed, why I didn't go to the sorority party, why I didn't go on that job interview comes up. And I think we're doing our patients a disservice if we don't acknowledge that. Um when a patient is sitting in the chair across from you and you watch their eyelids, their headlights dim, they look away from you, when you see them fidgeting and being distracted, it's the body language clue. And the reverse of that is when they come back for their second or third follow-up visit and they're engaged and they're open and their hair's done and their nails are polished and their shoes are shined. You know that they feel better about themselves and they're ready to present themselves. I mean, this would never happen in my generation, but you know, I've had people come back on their third or the fourth visit and gotten a tattoo because they're so they want to express their pride in themselves. And you you can see when they're walking down the hall to the exam room the change that they've experienced. And the the flip side of that is on their first visit, I I've often been their fifth or sixth or seventh dermatologist and their twelfth or thirteenth physician. And, you know, they say, well, I was given a cream, or I was told, you know, I'm too fat, or I smoke too much, or you know, your dad and mom had it. And it's, but you know, it's just, it's just skin. So, you know, you don't have brain cancer, so just suck it up. And um, you know, we've all seen people who leave a trail of scale when they undress in your office, and that's just such a shame. And uh we we hear their stories about what they don't do. Um, I've had kids that have gone to college uh virtually because they don't want to go into a classroom. I've seen kids that don't play sports because they don't want to undress in the locker room, and they've been told time and time again that these drugs aren't safe, it's not very effective, you know, creams are so much safer, which again is ironic because we all know that's not the case. Um so I think the amount of joy we can bring to a patient, and if you think about it, a long, long time ago, there was no quality of life data in any uh pivotal trial or research. And try to get an FDA to approve a drug in these days without a without a quality of life component, not gonna happen. Um, we recognize that uh different populations have different quality of life measurements. And whether it's a skin tone, whether it's a gender, whether it's an age, whether it's a specific demographic, different quality of life measures matter. And what I find very, very important when you're talking to a patient is for us to pitch the ball about mental health, to make it, you know, you we don't have any trouble saying, hey, do you itch? Right. Uh do you do you does it bother you when you're when your ear is draining and oozing? Uh I just right up front say, does this ever make you feel bad? Does this make you blue? Is it you get depressed about this? Because if you discuss it like it's an AE of the disease, people are willing to talk about it. It's just like saying, Do you have it on your feet? Do you have it up? Do you have it in your inner triton series? Is it in your pelvis? Oh, well, now that you bring it up, I do. That must not be too out of line. So I like to I'd like to just address the mental health component up front so that they know I get it, that they know I'm on their team, I'm their ombudman, if you will, uh, or one of them. And um, that allows them to feel comfortable having the conversation up front that let's talk about all the things that are bothering you about the psoriasis. Because there's nothing, you know, there's there's no topic that's off limits that the diagnosis and the therapeutics can't work together to fix.

Whole-Patient Approach And Comorbidities

SPEAKER_01 6:48

Yeah, and I think people should feel comfortable, you know, talking about that with their dermatologists. You know, they might think, oh, well, I'm just here for the skin part of the psoriasis, right? And maybe the mental health piece, you know, that should be my family doctor. Maybe if they already see a psychiatrist or a psychologist that gets relegated to them. And I think, you know, what you're pointing out is really important that people understand that your dermatologist gets that this affects, you know, how you feel emotionally, your ability to go to work, like you said, your ability to be intimate with your partner, your ability just to enjoy life and be out there in the game of life. And that's actually what inspired me to go into dermatology. A patient had psoriasis all over his body, biologics were just coming out, and he cleared and he actually got off disability and he was dating by the time I left. And I thought, wow, I mean, his life did a complete 180 and how impressive that we could be a part of that as a dermatologist. And when you've had a patient come in and obviously you're you're looking at their skin, addressing itch and the psoriasis, you know, tell me about, you know, someone maybe you recognize that clearly they were struggling with some symptoms of anxiety or depression. Maybe they didn't even recognize it themselves. And how do you approach that, you know, with a patient or how would you tell a patient to bring it up to you? Because I think that's the piece that crossover is how do you have that conversation even start?

A Captain’s Transformation Story

SPEAKER_02 8:03

So I think it's important that you feel comfortable. We, the providers, feel comfortable and confident in our ability to make their lives better and present it as I can make your skin feel better, I can make you not itch, I can make it look better, I can make you feel better. And not just the skin feel better, I can make you feel better all over. Because we used to think of psoriasis as a um skin disease. And we all know it's a multisystem pleomorphic disease that affects lots of things. And we address people like you're in you may be insulin resistant, you may have high, you know, dyslipidemia, you may have anxiety and depression. These are all parts of psoriasis. And as soon as people recognize that this is not something they did, ate, smoke, or thought, this is part of the disease process. And then the door cracks open. And oh, Shannon, I could tell you story, like I think like any dormant child can tell you stories of people who don't go on job interviews, who don't go to the sorority party, who who won't date, who um only wear clothes that are long and billowy, and because they're embarrassed, they're ashamed. It's like somehow, something I I did something, and this is this this is the penance I have to pay. And I I I think it's it brings me a quality of life improvement when I can disabuse them of that notion. Um, I I have a uh uh a great story of a guy. Uh I I live very near uh the Great Lakes, and I have a a patient that um is involved in the boating industry. And on a boat and like gear, I can tell you people wear very small bathing suits and always have a beer in their hand. And you know, they maybe do things we don't want them to do with the sun on a boat.

SPEAKER_01 10:02

But this we know you've got a speedo, Scott. We know you've got a speedo.

Destigmatizing Touch And Language

SPEAKER_02 10:05

Oh my god. Uh and so this gentleman um always wore long sleeves, always covered himself up, always wore shoes on his boat because he was so embarrassed about what he did. And his career was a charter boat captain, and he also maintained and sold boats. And every other person that does that has a certain uniform they wear. And he didn't fit in. And he was also the guy with the lawn pants and da-da-da-da-da. And you know the story. I met him, he we worked together uh up at Lake Erie. And at one point I saw him in short pants when he didn't think anybody was around. And um, I said, We can't have that. And and he thought he was burdening me. And I said, you know, everybody knows we're friends, and if they see that skin, they're gonna presume I'm your dermatologist and look at you, you look like hell. We can't have you looking like that. Um, and so we got him started on the appropriate therapeutic regimen. And I'm telling you, he is a different human being. He was single, he wasn't dating, and now he's had the same uh partner for, I don't know, seven years, and it's opened up an entire new quarter for his life. And every time he's meeting lake, he buys me a beer. And that's not why I'm treating him, but it's just I have a new friend because um he's been told forever, you know, it's just psoriasis, it's just your skin. And that reminds me to remind our colleagues that if I'm giving a formal lecture or talking to medical students or residents, people sometimes say, Well, I don't want to do this because you can have a blood test. Like, well, of course you have a blood test, you're a serratic patient, you probably have metabolic syndrome, or you're in your wedded metabolic syndrome. So you need you need to make sure all those things we talked about are are attended to. And when you get that patient who's got PASI 50, 60, 70, 80, and you give them the appropriate treatment, because we have so many now that are good and effective and safe, you can you can pretty much say to a patient, I'm gonna make you better. And then they say, Oh, yeah, right. I'm your you're my 10th dermatologist. And I'm gonna be your last one too, because I'm gonna take care of you. I really not that I don't give them a choice, but I look in their eyes and say, um we're we're uh gonna change the way you look at yourself. And we have to get rid of the blame, we have to get rid of the shame. Um and we also have to, part of that, to accomplish that, we have to get rid of the stigma that a small molecule or a shot is you know not some immunosuppression that's gonna kill you. And I tell people, your immune system is working crazy over time, and we need to regulate it. We need to uh immunonormalize. That's a phrase I'm stealing from one of our colleagues, not mine, but I like that phrase immunonormalize. Your immune system's crazy, so I'm gonna connect it.

Symptoms, Intimacy, And Openness

SPEAKER_01 13:06

Hold on just a minute. I'm gonna pause it. You cut out for like a brief moment. Is your internet strength okay where you're at? Uh I think so. Uh it's just 99%. Yep. Okay. All right. It cut out, it may just come across on my side, but not on the other side. So we'll we'll look at that. No worries, they'll cut this portion out. So, you know, I think then for somebody who has psoriasis, you know, I think you could definitely feel like or have the notion that obviously it's probably affecting them from a mental health standpoint. But how do you approach that with a patient? Now, clearly somebody might come out and say, oh gosh, Dr. Drew, like I can't even go to work. Like it itch so bad. I'm so embarrassed. I want people to see my skin. But for somebody that maybe it's not so obvious, how do you sort of tease that out? What sort of questions do you ask, or how do you try to get an idea of how their psoriasis is affecting them?

Side Effects Versus Doing Nothing

Do Medicines Cause Depression?

Set Expectations And Guardrails

Efficiency Grows As Patients Improve

A Message Of Hope And Progress

SPEAKER_02 13:55

Right. So the first patient you identified, that's easy. They're bought in, they come in saying, What kind of Girl Scout cookie can I buy? You know you're making the sale. Um, but more commonly, if a if a person comes in with a spouse and the patient says, Oh, it really doesn't bother me, and the spouse like smacks him on the shoulder and says, Yes, it does, you because uh you have blood on the sheets every morning, you're up at night scratching it again, you wake up at two in the morning and put lotion on, it does bother you. Yeah, it does. And you know, getting an old guy to admit he's blue about something is very, very tough. So I I always make a point, and uh uh this may sound somewhat controversial, but uh I always touch the patient and I always touch them where they have a big thick plaque. And I like pet their psoriasis. Like, I'm not scared of you. I don't think you have leprosy. I don't think your psoriasis is not contagious, and you shouldn't be scared of it. You have psoriasis, you are not a psoriatic. And I sometimes I say that phrase and um and I look in their eye and I say, Oh, we we need to get rid of this. I know it bothers you. And I tell them things that I hear commonly from other patients. Man, you must sometimes not want to like wear flip-flops because your toenails are you know full of the signs of psoriasis. I can get psoriasis in my toenails, and I grab their foot and say, You see these little dents in them? Those are called pits, and we can fix that. And see how it's cracking at the end? That's called onocolysis. We can fix that for you. Oh, oh. And I said, and though, you know, those interleukins, those funny words we talk about, they can land in your in your joints and they can really destroy your joint. We make that better. And I try to loop in heart and like and joints and skin and lipids and make it all part of the conversation so that um it doesn't have the stigma of mental health issues. You know, we can walk into a lecture or a party and say, you know, I don't feel very good today. I I hit my elbow and I had to have injected, and people go, oh. But you can't walk into a party in 2026 and say, Oh, didn't I come tonight? Because I had some suicidal ideation and I didn't, I didn't really think it was appropriate. Because we as a society don't talk about mental health, at least very comfortably. So I like to just put it out on the table. You might not like anchovies, but they're on the buffet if you want one. And so we just flat out say, you know, I'm sure some days when you get out of bed and you look at your knee and it's a mess, you just feel depressed and don't want to do stuff. And they go, I don't. And if you don't run out of the room screaming because you're, you know, you're afraid of them, that makes them feel like they can trust you and that you get it, and they are not your first horizon patient. And when you empower them, I I I have heard some of my colleagues say, Oh, my patients would never do that. I'm like, really? Because if you do enough research and do your homework, I think that you most patients will they're coming to you because they want you to make them better. And if you convince them that you have the tools to make them better, they will work with you to use those tools. Now it might take a little more time to talk about talk about SIB or whatever side effect they're worried about. And um that I think that will help you help them buy into the therapeutics. But I think the key is that you have to acknowledge that mental health issues are there. Now, I'm really mainly talking about anxiety and depression, uh, perhaps suicidal ideation. The the numbers for like the serious, the ultra serious uh schizophrenia, you know, those numbers are higher, but still on the low single digits. The depression anxiety numbers, you know, they're well into the 20s, 30s, and 40s percent of patients, but it's not a steady state, it's not homeostatic. I mean, one day you're on vacation with your family, you're at the beach, you're and you're you're okay. But one day you're at work and the new kid comes in and he's young and virile and doing hoops and playing ball, and you've got joint pain, well, then it may flare up a little bit. So I think it's an ongoing conversation. You know, you so someone's got dyslipidemia from their part of their metabolic syndrome, and so they're uh being treated by somebody. They don't think about their cholesterol every day. I mean, they maybe think about it if they get an ice cream sandage or something or something. But the joint pain of psoriasis, the the the blueness of not being able to get out of bed in the morning, the the uh anhedonia of not wanting to have intimacy with your partner because you're embarrassed by the genital psoriasis, or your partner is scared of the genital psoriasis, or perhaps the patient's spouse or partner isn't aware of it and thinks it's not psoriasis, but something else. And that just adds to the mental health depression. We have to hit this ball right in the strike zone and um discuss it, not like it's a stigma, but that it's a symptom. And when the when the psoriasis and the plaques goes away, go away, people feel better. So it's uh when when I give a talk about psoriasis and get to the side effect section, I always start with what is a side effect of doing nothing. And yes, we have side effects of, you know, we have mace events and we have DVTs and we have joint pain and we have injection site reactions. All those things are side effects. And they're in the the percentage numbers that we all know about. What we don't know about, what is the risk of SIB for a college-age kid who's got psoriasis, is the only kid on campus who knows who's got psoriasis, and we just say, you know, it's really not that bad. Just put some triumph on it and I'll see you in a year. We have to acknowledge, remember what it was like when we were in college. Oh my gosh, it's the first warm day of summer. Let's go out to the college green and get those inflatable pools and jump in the pool and have a beer and try to impress the sorority girls across the street from us. Well, that's a that's going away when you've got plaques in your elbows, knees, face, scalp, ears, and fingernails. So I think the acknowledgement of the impact that this it's just skin disease has on people. And you know, there are um websites. The NPF uh has websites for parents that they can go to. Um, they have um uh the AAD has partnership programs for other pay where patients can meet other patients and understand that they're not the only um patient on the planet that's got psoriasis. Now, sometimes that gets out of hand, obviously, because they come in and say, hey, I read the teacher, oh, it will fix my psoriasis. And and what's the root cause of my psoriasis? And that go down a rabbit hole, obviously. But I think it's important to empower people to talk about it and um and people bond and and become friends over their shared experiences. And I think it's important that we empower that as well.

SPEAKER_01 21:31

Well, one of the things I wanted to pull out from what you just talked about is you mentioned side effects, right? And how that sort of makes some people pause. And I feel like in particular with psoriasis, because you some of the medications that we know that work very well, they might see listed in the clinical trials or where they were studying that patients did report depression, anxiety, or thought about committing suicide. Or maybe we, you know, we have a medication, obviously, where there was a completion of a suicide. We've seen this before, you know, in trials. A lot of Patients then automatically jump to the conclusion that, oh, it must be the medicine, right? So I was gonna have you kind of help fix that sort of perception because some of our listeners out there, I think, kind of think that way versus the fact that we know anxiety, depression one and a half times, you know, greater risk of developing that patients who have psoriasis versus those that do not. And then also just maybe some evidence that the same inflammatory cytokine profile that, you know, fuels psoriasis may actually help fuel depression anxiety as well. So I was gonna have you comment a little bit because I think that's something we need to clear the air on that might help some of our listeners that have been hesitant to do therapy because they might be thinking it's gonna make depression anxiety worse based on what they've heard.

SPEAKER_02 22:38

Well, you had just uh opened Pandora's box, and I uh I am so I always do that at the end of the podcast, just for I am so happy you said that because so uh so first on the inflammatory part of this. You know, uh back in my residency, we all thought psoriasis was caused by too much S1 of mitosis. And if you somehow fix that, you'd be fine. Um and now we know that this is this multifactorial inflammatory cascade of events. Well, that same series of events is happening in many, many, many systems. Well, of course it's happening in the central nervous system. So in in and there's lots of ongoing studies that that are uh in in in style or uh in process now to validate that. Um and we have plenty of evidence that depression and anxiety go down uh uh directly proportional to your BSA and your PASI score. We know that. Um and so I think it's important for patients to understand that anxiety, depression, and SIB is part of the disease process. And how you do that is by talking about it and understanding among our colleagues, again, as I said earlier, when I was a resident, nobody asked a single, nobody cared about quality of life. Um suck it up. And now we know that that's not the way it is. Now, I'm not suggesting that we somehow empower this cocooness. In fact, uh I tell people if someone makes fun of your psoriasis, that's on them, not on you. You know, that just shows their lack of understanding and lack of compassion, lack of empathy and lack of intelligence. Um, and I try to um let people know that you are bigger than this disease, and it's my job to help you be taller, be stronger, be faster, be wiser with this disease that you have, because we have so many safe tools. And I think it's important that our young resident education programs um continue to aggressively educate um uh young these young providers on the totality of uh the patient experience. Um, because again, they've been told time and time again by providers, uh, uh, and and and educational programs for non-derm providers, the the people that send patients to us. I don't think everyone needs to know about every single IL-12, IL-23, IL 31, IL 4, IL-13, JAC inhibitor. That's, you know, non-derms are busy doing their own thing. But I think it is important for us uh to talk to those groups at county medical society meetings or national PEADs or national FP meetings about safety, efficacy, availability, mental health issues so they know they can come to us and you know, bust some of these myths that, oh, your drugs are immunosuppressive or pro-infective. Um, the biggest reason my patients stop drugs is they've been told by their surgeon of whatever specialty that I don't want you to get an infection post-ops, we're gonna stop your drug for the next two to four to six to eight to ten weeks. Like, and I tell patients, do not stop anything unless you ask me first. And if there's some conflict, then I pick up the phone and call the the relative person to that. Um but I think of did I there's a was there a part I missed about your question? I think it was one other thing I wanted to say, but I forget what it was.

SPEAKER_01 26:18

So I just asked about like the the medications, like how people blame the medication for causing depression and anxiety. Yep, yep, yep. Because I do think that's what a lot of people think, you know, when they see that as a side effect or an adverse event listed.

SPEAKER_02 26:29

Yep. And so it's interesting in the post-marketing data, the most common drug or the drug that most commonly has had suicidal ideations is that alumimab. And that does not have a box warning or or any warning about suicidalation and behavior. Um, and that's first off, it's been around the longest, you might actually assume that. But the newer drugs, though, like the 2.0s and 3.0s and the 17A class or 17AF class, um, you know, their post-marketing suicide rates are far less per capita. And um, I think it's important for us to put guardrails around uh AE understanding. Because, you know, it's it's kind of like saying, oh, don't worry about that office on the fourth floor. There's no bombs up there, so don't worry about that. Well, immediately everyone worries about what's going on on the fourth floor. Uh, so I I think it's important when when uh when we say to patients psoriasis makes people depressed, and some people who are depressed think about suicide. We're gonna make you not depressed because your psoriasis is gonna be less, if at all, present. Because you know the NPF guidelines are 99% clear 99% of the time within 90 days of treatment. And so we're supposed to be empowered to tell people that on their first visit. And unless there's some preexisting organic depression, when they hear that, they're like, wait, in three months, I'm gonna be clear the vast majority of the time? What? I mean, you you get you get a visceral emotional reaction from them. You mean uh uh I I'm gonna be better in time for my bathing suit? And they're incredulous. And so as long as you uh understand the data and give them the data, I think it's a pretty easy conversation to have. Now, I gotta tell you, some of these drugs have REMS programs and some have an SIB warning on them that makes it a little more difficult and makes your visit longer because you have to extrapolate that a little bit. But if you look at the forest, not the tree, your second, third, and fourth visit are so much quicker because they get better. You walk in the room, how you doing? I am great. How's your stress? Oh my god, I can't believe how good it looks. Are you feeling blue? Have any side effects? Do you have any conductivitis? Do you have any joint pain? Do you have any infections? No, no, no, no, no. I I won't be in this forever. Um it's a it's a quicker visit. So I think if you look at it on a global perspective, it's a much easier drug to write. And then they tell two friends who tell two friends, who tell two friends, and all of a sudden your appointment schedule is filled. Um, so I don't, I don't really, um, I don't really buy into the I don't have time to write these advanced therapies. Because I think if you invest a little bit of time at the front end, the back end pays for itself.

SPEAKER_01 29:25

Wow. That I think that's so important for people to understand. And, you know, kind of as we just wrap up here, you know, I always learn so much from you, Scott, even now. Uh it's so funny going back to training and even the new things and insights that I get from having conversations with you about patients. But I want you to leave our audience with kind of what your message is of hope, you know, for somebody who's struggling with uh skin condition psoriasis, hydronitis separativa, you know, for those people that are dealing with mental health issues related to, and maybe sometimes even separate. They could have existed prior. What is your message of hope for our audience out there?

SPEAKER_02 29:59

So, you know, HS is a different disease. We're not, I can't deliver the promises for HS that I deliver for psoriasis. But for AD and HS, I can, uh AD and psoriasis, I can, and for HS, I can certainly give the promise or I'm going to make you better. But in 2025, there's no time in human history that's better to be a dermatologist. Because we can offer hope to every patient who walks in that door. I mean, I don't think there's a single patient on the planet that isn't a candidate for one of these advanced therapies that will not get better, particularly psoriasis. And when you have a patient tell them, tell you about their story of how their life has changed. I was able to go to my daughter's FFA competition. My son got married, my uh, my granddaughter uh had a bar mitzvah, and I was there to watch this, and I couldn't have done it before. Thank you, doctor, for helping me do this. And you tell another patient that story. Like, I used to, I used to love bowling, but I can't because my my finger won't fit in the bowling ball hall anymore. Like, we we can help you with that because they've been told so often. So hope is the word. Hope and the the the promise of improvement. So and and Shannon, I I I I have to tell you, I am so proud of you. I can't sit on the internet without seeing the lecturer in Hawaii or in Florida or writing a paper, or uh it gives me great glee to sit around and watch an expert panel, uh an acclaimed expert panel, and you are sitting on it. It's just like makes my day. So congratulations to you and your beautiful family.

SPEAKER_01 31:46

Well, thank you so very much. And and thanks, Scott, for coming on the podcast. Always love getting your insights. I know your psoriasis patients. I mean, you've made such a difference in their world and their lives, and I know they're incredibly lucky to have you. And so is our audience for having the opportunity to listen to your insights today. So stay tuned for the next episode of Dermot Trotter. Don't swear about skincare.

SPEAKER_00 32:07

Thanks for listening to Dermot Trotter. For more about skincare, visit dermittrotter.com. Don't forget to subscribe, leave a review, and share this podcast with anyone who needs a little skincare sanity. Until next time, stay skin smart.